ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

USMJ North American Cannabis Holdings Inc (CE)

0.000001
0.00 (0.00%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
North American Cannabis Holdings Inc (CE) USOTC:USMJ OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

USMJ Announces New York Adult Use Cannabis License

09/08/2022 3:21pm

InvestorsHub NewsWire


Dallas, TX -- August 9, 2022 -- InvestorsHub NewsWire -- North American Cannabis Holdings, Inc. (USOTC: USMJ) today announced securing an adult use cannabis cultivation license in the State of New York.

In February of this year, New York passed a new law to provide provisional marijuana cultivation licenses to existing hemp businesses.

USMJ has a subsidiary that has been growing hemp for CBD for the past four years. The company announced in March of this year, that its subsidiary had received an invitation from the New York Office of Cannabis Management (OCM) to apply for the provisional adult-use cannabis license.  Today, USMJ announces that the license has been awarded.

In light of the license, USMJ and its sister company, Puration, Inc. (USOTC: PURA) are reviewing current business plans and exploring an update to the existing strategy of both companies.

Contact:
USMJ
Steven Rash
info@aciconglomerated.com
+1 (800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

 

 

1 Year North American Cannabis (CE) Chart

1 Year North American Cannabis (CE) Chart

1 Month North American Cannabis (CE) Chart

1 Month North American Cannabis (CE) Chart

Your Recent History

Delayed Upgrade Clock